ESTIMATING THE COST EFFECTIVENESS IN THE UK OF VILDAGLIPTIN COMPARED TO PIOGLITAZONE AS ADD-ON THERAPY TO METFORMIN USING THE SHEFFIELD TYPE 2 DIABETES MODEL

被引：1
|
作者：
Brennan, A. [1 ]
Gillett, M. [1 ]
Duenas, A. [1 ]
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66666-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A501 / A501
页数：1
相关论文
共 50 条
  • [41] Empagliflozin as add-on to metformin in people with Type 2 diabetes
    Merker, L.
    Haering, H-U.
    Christiansen, A. V.
    Roux, F.
    Salsali, A.
    Kim, G.
    Meinicke, T.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 (12) : 1555 - 1567
  • [42] Cost-Effectiveness Analysis on Pioglitazone Add-On Therapy to Patients Failing Insulin
    Gschwend, M. H.
    Beaudet, A.
    Heddaeus, H.
    Lange, M.
    Kremer-Koenig, J.
    Landers, B.
    Schlaeger, C.
    Sandtmann, R.
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2011, 16 (06): : 355 - 362
  • [43] Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes
    Li, Feng-fei
    Shen, Yun
    Sun, Rui
    Zhang, Dan-feng
    Jin, Xing
    Zhai, Xiao-fang
    Chen, Mao-yuan
    Su, Xiao-fei
    Wu, Jin-dan
    Ye, Lei
    Ma, Jian-hua
    DIABETES THERAPY, 2017, 8 (05) : 1111 - 1122
  • [44] Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes
    Feng-fei Li
    Yun Shen
    Rui Sun
    Dan-feng Zhang
    Xing Jin
    Xiao-fang Zhai
    Mao-yuan Chen
    Xiao-fei Su
    Jin-dan Wu
    Lei Ye
    Jian-hua Ma
    Diabetes Therapy, 2017, 8 : 1111 - 1122
  • [45] Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin
    Bolli, G.
    Dotta, F.
    Colin, L.
    Minic, B.
    Goodman, M.
    DIABETES OBESITY & METABOLISM, 2009, 11 (06): : 589 - 595
  • [46] Efficacy and Safety of Saxagliptin Add-on to Metformin Compared with Acarbose Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin Monotherapy
    Du, Jin
    Liang, Li
    Fang, Hui
    Xu, Fengmei
    Li, Wei
    Shen, Liya
    Mu, Yiming
    DIABETES, 2016, 65 : A293 - A293
  • [47] Cost-Effectiveness of Subcutaneous Semaglutide vs. Empagliflozin as Add-On Therapy for Type 2 Diabetes
    Zupa, Margaret
    Codario, Ronald
    Smith, Kenneth J.
    DIABETES, 2021, 70
  • [48] Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study
    Zang, Li
    Han, Yin
    Chen, Lixian
    Hu, Daqing
    Jin, Hui
    Yang, Nailong
    Shi, Xiaoyun
    Liang, Linlang
    Liu, Mingming
    Fan, Hong
    Li, Quanmin
    Mu, Yiming
    DIABETES THERAPY, 2019, 10 (04) : 1391 - 1405
  • [49] PROactive 06:: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK
    Valentine, W. J.
    Bottomley, J. M.
    Palmer, A. J.
    Braendle, M.
    Foos, V.
    Williams, R.
    Dormandy, J. A.
    Yates, J.
    Tan, M. H.
    Massi-Benedetti, M.
    DIABETIC MEDICINE, 2007, 24 (09) : 982 - 1002
  • [50] Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study
    Li Zang
    Yin Han
    Lixian Chen
    Daqing Hu
    Hui Jin
    Nailong Yang
    Xiaoyun Shi
    Linlang Liang
    Mingming Liu
    Hong Fan
    Quanmin Li
    Yiming Mu
    Diabetes Therapy, 2019, 10 : 1391 - 1405
12345